Clinical Trials - Physician

Use the search below to find a complete list of what is available in our state and who you can contact for more information.

Title	Phase	Contact(s)
Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) after Neoadjuvant Chemotherapy (S1418)	III	Mary Beth Wilwerding, RN mwilwerding@canceralliance-ne.org Phone 402-991-8070 Fax 402-991-8850
Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy after Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer (AFT-38)	III	Mary Beth Wilwerding, RN mwilwerding@canceralliance-ne.org Phone 402-991-8070 Fax 402-991-8850

Pages

Become a NOS Member Today!